Keywords: Sandoz, Sanofi-Aventis, Lovenox, Citizen petition, Biosimilars, Deep vein thrombosis

US FDA approves first generic of Sanofi-Aventis’ Lovenox for Sandoz, for DVT prevention

Article | 26 July 2010

Print This

The US Food and Drug Administration delivered a blow to Sanofi-Aventis on Friday, when it approved the first generic version ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in